2-Methyloxazole-4-carboxylic acid

Catalog No.: 
ACOZMS241
CAS No.: 
23012-17-1
Molecular Formula: 
C5H5NO3
Molecular Weight: 
127.10
2-Methyloxazole-4-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$111.00In stockInquiry
10g98%$214.00In stockIn stock
25g98%$347.00In stockIn stock
100g98%$1388.00In stockIn stock
500g98%$6004.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Methyloxazole-4-carboxylic acid
IUPAC Name2-methyloxazole-4-carboxylic acid
MDL No.MFCD00234078
Molecular FormulaC5H5NO3
Molecular Weight127.10
SMILESCC1=NC(=CO1)C(O)=O
InChI KeyIARMCEYEYXXEOS-UHFFFAOYSA-N
Synonym2-Methyloxazole-4-carboxylic acid | 2-Methyl-1,3-oxazole-4-carboxylic acid | 23012-17-1 | 23062-17-1 | 2-methyl-oxazole-4-carboxylic acid | 4-oxazolecarboxylic acid, 2-methyl- | MFCD00234078 | 2-methyloxazole-4-carboxylicacid | 2-Methyloxa | Oxazole-4-carboxylic acid, 2-me
CAS No.23012-17-1
PubChem CID539404

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H319
Precautionary Statement(s)
P305+P351+P338

Synthetic Route by SureRoute

1. ACOZMS241 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEYRG438 route compound structure diagram
    ACEYRG43885806-67-3In Stock
  2. Then
  3. ACOZMS241 route product structure diagram
    ACOZMS24123012-17-1In Stock
Inquiry

2. ACOZMS241 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHCMT650 route compound structure diagram
    ACHCMT65010200-43-8In Stock
  2. Then
  3. ACOZMS241 route product structure diagram
    ACOZMS24123012-17-1In Stock
Inquiry

3. ACOZMS241 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOZMS241 route product structure diagram
    ACOZMS24123012-17-1In Stock
Inquiry

Comments (0)